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of dysfunctional segments/patient (11.4+3.0 vs 11.0+3.0), global wall motion score index
(WMSI: 2.37+0.36 vs 2.12+0.42), and ejection fraction (EF: 29+9% vs 35+8% p=NS).
However, in patients with RF pattern the number of segments/patient showing contractile
response to dobutamine (3.50+2.43 vs 6.63+2.59; p<0.01) and the percent contractile
reserve (31+22% vs 65+22%; p<0.0001) were lower compared to NRF patients, and
WMSI at peak dobutamine infusion higher (1.93+0.24 vs 1.60+0.36; p<0.05), indicating
reduced contractile reserve in patients with impaired diastolic filling. Across all patients
there was also a positive correlation between the number of segments showing contrac-
tile reserve and both isovolumic relaxation time (r=0.64, p<0.0001), and deceleration
time of peak E-velocity (r=0.56, p<0.001). After revascularization, LVEF increased by
11+9% in patients with NRF but by only 4+3% in patients with RF pattern (p<0.05). Also,
in patients with NRF compared to RF pattern, function recovered in 4.22+4.0 segments
vs 1.75+3.0, and WMSI improved by 0.44+0.42 vs by 0.33+0.40 (p<0.05), respectively.
Conclusions: In patients with hibernating myocardium, impaired diastolic filling is asso-
ciated with reduced contractile reserve; restrictive filling pattern may also predict poor
recovery of function after revascularization.
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Athanasios Kotsakis, Valerios Foulidis, Takis Xidas, Evangelos Papasteriadis, Nikea 
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Background: Levosimendan is a new calcium-sensitizer agent with inotropic and diuretic
properties. Although it is used as an inotropic agent in decompensated heart failure
showing comparable efficacy to the other inotropic drugs, it has not been used in stress
echocardiography yet. The purpose of our study was to compare the accuracy of levosi-
mendan (LSE) and dobutamine stress echocardiography (DSE) for the prediction of
recovery of left ventricular (LV) dyssynergies after revascularization.
Methods: Twenty eight patients with LV dysfunction due to previous myocardial infarction
scheduled for revascularisation (18 coronary angioplasty and 10 bypass surgery) under-
went low-dose DSE (5-10µgr/kgr/min) and LSE. Levosimendan was infused at least 1
hour after dobutamine infusion, at 2 doses of 12 and 24µgr/kgr, over a 5 minutes period
each. LV wall motion score was assessed using a 16-segment model. Myocardial viability
was detected if improvement of >1 grade of regional wall motion score in at least two
contiguous segments was noted, during either dobutamine or levosimendan infusion. All
patients also underwent resting echocardiography within 6 months after successful
revascularization.
Results: No major adverse events occurred during levosimendan or dobutamine admin-
istration. Of the 448 segments studied, 212 (47%) were dyssynergic at rest. Dobutamine
infusion resulted in augmented contraction in 98/212 (46%) abnormal segments while 88
(90%) of them showed functional improvement after revascularization. During LSE 110/
220 (52%) dysfunctional segments improved and 100 (91%) of them recovered function
after revascularization. Analysis of results showed a significantly lower sensitivity of DSE
compared to LSE (73% Versus 94% respectively, p<0.01) but a similar specificity (88%
Versus 90% respectively, p=ns) for the prediction of the recovery of LV dyssynergies after
revascularization.
Conclusions: Levosimendan can be used safely in stress echocardiography. Futher-
more, LSE seems to predict postrevascularization recovery of LV dysfunction with higher
accuracy than DSE.
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802-3 Comparative Long-Term Prognostic Value of 
Dobutamine Stress Echocardiography Versus 
Dobutamine Stress Myocardial Perfusion SPECT
Arend F.L. Schinkel, Jeroen J. Bax, Abdou Elhendy, Don Poldermans, Erasmus MC, 
Rotterdam, The Netherlands
Objectives: The purpose of this study was to compare the long-term prognostic value of
dobutamine stress echocardiography and dobutamine stress single photon emission
computed tomography (SPECT).
Background: Dobutamine stress echocardiography and dobutamine stress SPECT are
clinically useful methods for the detection of coronary artery disease. The comparative
longterm prognostic value of these imaging modalities is not clear.
Methods: A total of 354 consecutive patients underwent simultaneous dobutamine
stress 99mTc-sestamibi SPECT and dobutamine stress echocardiography. Follow-up
was successful in 351 (99.2%) patients. Fifty patients underwent early (<60 days) revas-
cularization and were excluded; the analysis is based on 301 patients.
Results: Abnormal perfusion was detected in 198 (66%) patients, and 182 (60%) had an
abnormal stress echocardiography; the agreement was 82% (kappa=0.62). During 7.3
{plus minus} 2.8 years follow-up, 100 (33%) deaths occurred of which 43 (43%) were due
to cardiac causes. Nonfatal infarction occurred in 23 (8%) patients and 29 (10%) under-
went late revascularization. Annual event rates for cardiac death, or all cardiac events
were respectively, 0.7%, and 3.6% after a normal scan, and 2.6%, and 6.5% after an
abnormal scan, P<0.0001. For stress echocardiography, annual event rates for cardiac
death, or all cardiac events were, respectively, 0.6%, and 3.3% after a normal test, and
2.8%, and 6.9% after an abnormal test, P<0.0001. In multivariable Cox models, 99mTc-
sestamibi SPECT and stress echocardiography were the strongest predictors of cardiac
death (OR 2.4, CI 1.1-6.5 and OR 3.3, CI 1.2-8.7, respectively) and all cardiac events
(OR 2.3 CI 1.1-4.9 and OR 3.4 CI 1.7-6.8). Both modalities had a similar incremental
prognostic value over clinical variables (SPECT vs. echocardiography: global chi-square
33.2 vs. 36.0, P=NS).
Conclusions: Dobutamine stress 99mTc-sestamibi SPECT as well as dobutamine
stress echocardiography provide comparable, powerful, long-term prognostic information
over clinical data.
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802-4 The Doppler Tei Index During Dobutamine Stress 
Echocardiography: A Powerful Predictor of Mortality 
After Acute Myocardial Infarction
Betina Norager, Mirza Husic, Jacob Moller, Kenneth Egstrup, Svendborg Hospital, 
Svendborg, Denmark, Odense University Hospital, Odense, Denmark
Background: Myocardial viability can be detected by systolic wall motion analyses dur-
ing dobutamine stress echocardiography (DSE). However, not only systolic but also dias-
tolic left ventricular function has a potential of improvement after acute myocardial
infarction (AMI). Therefore, we hypothesized that the Doppler Tei index of combined sys-
tolic and diastolic performance (sum of isovolumic relaxation and contraction times
divided by ejection time) obtained during DSE could provide prognostic information
beyond conventional systolic wall motion analyses.
Methods: In 162 consecutive patients with first myocardial infarction DSE (10 µg/kg/min)
was performed 16 ± 6 hours after hospital admission. Delta Tei index was calculated as
the change in Tei index from rest to DSE.
Results: During follow-up of 25 ± 11 months, 33 patients (20 %) died. Delta Tei index
was significantly higher in survivors than in patients dying (0.05 ± 0.09 versus -0.08 ±
0.11, p < 0.0001). Mortality rate was significantly lower in patients with delta Tei index
above the median (0.03), p < 0.0001 (Figure). In a multivariate Cox regression model,
delta Tei index (chi-square = 8.1, p = 0.004) added prognostic information above and
beyond age, Killip class II > on admission, ejection fraction, mitral deceleration time < 140
ms, and infarct zone viability.
Conclusions: Tei index obtained during DSE is a powerful predictor of mortality after
AMI and provides prognostic information incremental to conventional stress echocardio-
graphic data.
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802-5 Long-Term Prognostic Value of Pacing Stress 
Echocardiography Compared With Dipyridamole Tl201 
Tomography in Patients With Permanent Pacemaker 
and Known or Suspected Coronary Artery Disease
Sarah Shimoni, Sorel Goland, Shay Livshitz, Gera Gendelman, Avraham Caspi, 
Menashe Epstein, Kaplan Medical Center, Rehovot, Israel
Background: Myocardial ischemia is difficult to assess by noninvasive methods in
patients (pts) with permanent pacemaker (PP).Recently, pacing stress echocardiography
(PSE) using external programming of the PP has been used successfully for detection of
coronary artery disease (CAD). However, the prognostic value of this method is not well
defined.
Methods: We compared the long-term prognosis of PSE and radionuclide tomography
(SPECT) in 46 pts (mean age 75 yr) with PP and known or suspected CAD. All pts under-
went PSE with increasing pacing rate up to 100% of age predicted maximal heart rate or
upper limit of pacemaker rate. Forty-one pts also underwent dipyridamole SPECT. Pts
were followed for a median of 570 days (range, 60-870). Event-free survival was esti-
mated using Kaplan-Meyer analysis.
Results: PSE was negative in 17 and positive in 29 pts. SPECT was negative in 8 and
positive in 33 pts. During follow up there were 15 cardiac events (death, myocardial inf-
arction and need for revascularization). The projected two-year event free survival was
81±13% in pts with normal PSE and 24%±18% when the PSE was abnormal (p=0.03).
Predicted two-year event free survival was 41±19% and 88±11% in pts with abnormal
and normal SPECT, respectively (p=NS).
Conclusions: PSE allows effective risk stratification in pts with PP known or suspected to
have coronary artery disease. The prognostic value of PSE is better than SPECT in this
population. PSE merits further study in a larger prospective comparative study.
